Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation. Issue 4 (13th July 2017)

Record Type:: Journal Article
Title:: Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation. Issue 4 (13th July 2017)
Main Title:: Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation
Authors:: Rivera-Caravaca, José Miguel
Lip, Gregory Y H
Abstract:
Is Part Of:: Evidence-based medicine. Volume 22:Issue 4(2017)
Journal:: Evidence-based medicine
Issue:: Volume 22:Issue 4(2017)
Issue Display:: Volume 22, Issue 4 (2017)
Year:: 2017
Volume:: 22
Issue:: 4
Issue Sort Value:: 2017-0022-0004-0000
Page Start:: 154
Page End:: 155
Publication Date:: 2017-07-13
Subjects:: cardiology
Evidence-based medicine -- Periodicals
616
Journal URLs:: http://ebm.bmj.com/ ↗
http://ebm.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/ebmed-2017-110764 ↗
Languages:: English
ISSNs:: 1356-5524
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19580.xml